News
The Defence Research and Development Organisation Has Given Mankind Pharma ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, 'The Defence Research and Development Organisation has given Mankind Pharma the license to manufacture and market the oral 2-deoxy-D-glucose for the treatment of #COVID19, the pharmaceutical company said on Thursday.'
The Defence Research and Development Organisation (@DRDO_India) has given Mankind Pharma the license to manufacture and market the oral 2-deoxy-D-glucose (2-DG) for the treatment of #COVID19, the pharmaceutical company said on Thursday. pic.twitter.com/068giYoUaB— IANS Tweets (@ians_india) July 8, 2021
(The above story first appeared on LatestLY on Jul 08, 2021 06:44 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
